Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Stock Short Interest Climbs 108.7%

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the target of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 50,920 shares, an increase of 108.7% from the September 15th total of 24,397 shares. Based on an average daily trading volume, of 60,698 shares, the short-interest ratio is presently 0.8 days. Approximately 0.5% of the shares of the company are short sold.

Columbia Research Enhanced Value ETF Stock Up 0.0%

REVS opened at $33.76 on Wednesday. The firm has a market cap of $371.36 million, a price-to-earnings ratio of 16.41 and a beta of 0.79. Columbia Research Enhanced Value ETF has a fifty-two week low of $27.24 and a fifty-two week high of $34.55. The company’s 50-day moving average price is $33.67 and its 200 day moving average price is $32.08.

Institutional Trading of Columbia Research Enhanced Value ETF

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Ruggaard & Associates LLC lifted its position in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock valued at $1,500,000 after purchasing an additional 322 shares during the last quarter. Private Advisor Group LLC boosted its stake in Columbia Research Enhanced Value ETF by 2.2% during the 1st quarter. Private Advisor Group LLC now owns 42,408 shares of the company’s stock valued at $1,214,000 after purchasing an additional 922 shares during the period. CoreCap Advisors LLC bought a new position in Columbia Research Enhanced Value ETF in the 3rd quarter worth about $30,000. Western Wealth Management LLC bought a new position in Columbia Research Enhanced Value ETF in the 1st quarter worth about $29,000. Finally, Farther Finance Advisors LLC bought a new position in Columbia Research Enhanced Value ETF in the 3rd quarter worth about $40,000.

About Columbia Research Enhanced Value ETF

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.